Backed by Korea’s S&S LAB and Indonesia’s Future Lestari, Turion Labs is building Southeast Asia’s first full-stack biotech innovation platform — with its flagship site at Sinarmas Land Biomedical Hub and expansion plans across the region. 

Turion Labs, a pioneering biotech venture formed by S&S LAB Korea and Future Lestari (Indonesia), officially launched in Singapore today during Ecosperity Week, unveiling a transformative vision to position Southeast Asia as a global innovation engine for medical and life sciences. 

Designed as the region’s first full-stack biotech innovation platform, Turion Labs integrates shared laboratory infrastructure, contract research services (CRO), and regulatory enablement into a unified solution that supports biomedtech ventures from discovery to commercialization. 

“We’re bridging the gap between high-potential science and scalable solutions,” said Dominic Jeong, CEO of S&S LAB Korea. “With Southeast Asia as our launchpad, we are building a connected platform that empowers global biotech innovators to gain access to Korean R&D excellence, Southeast Asian market pathways, and world-class lab infrastructure.” 

Turion Labs’ first major facility is set to open later this year at the Sinarmas Land Biomedical Hub in BSD City, Indonesia — a newly designated Biomedical Special Economic Zone. This flagship site will host modular labs, pilot-scale research suites, and clinical support services, creating a powerful springboard for biotech development and commercialization. 

“Turion Labs is a platform for acceleration — a place where biotech ideas become real-world impact. We are creating a robust ecosystem for regional and global innovators, enabling faster product development, streamlined regulation, and expanded market access, all rooted in Southeast Asia,” said Cynthia Krisanti, Director of Future Lestari. The launch was also attended by H.E. Prof. Dr. Pratikno, Indonesia’s Coordinating Minister for Human Development and Cultural Affairs, who witnessed the event and expressed his support for the initiative, underscoring its potential to advance regional health and nutrition sectors. 

As part of its long-term strategy, Turion Labs is expanding its presence beyond Singapore and Indonesia, with upcoming projects planned in Thailand, Malaysia, and the Philippines. These efforts will form a distributed, cross-border biotech corridor designed to attract venture capital, connect research hubs, and reduce barriers to growth for life science startups and scaleups alike.

About Turion Labs 

Turion Labs is Southeast Asia’s first full-stack biotech innovation platform. A joint venture between Future Lestari (Indonesia) and S&S LAB Korea, Turion Labs delivers shared lab infrastructure, CRO services, and regulatory enablement for biotech ventures across ASEAN. Headquartered in Singapore with its flagship site at the Sinarmas Land Biomedical Hub in Indonesia, Turion Labs is building a regional engine for life sciences innovation and investment.